Dr. Risa L. Wong, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Yale University School of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 87
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: Yale University School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
PA license MD476269
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
- Magee Womens Hospital of UPMC Health System Pittsburgh, PA
- UPMC PAssavant Pittsburgh, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
- Oncology Hematology Association Inc (202 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 87
- Services billed
- 258
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 102 | 27 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | 15 |
| New patient office or other outpatient visit, 60-74 minutes | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Abiraterone Acetate | 80 |
| Prednisone Other prescribers in Pittsburgh, PA | 73 |
| Orgovyx (relugolix) | 66 |
| Nubeqa (darolutamide) | 45 |
| Xtandi (enzalutamide) | 42 |
| Welireg (belzutifan) | 24 |
| Bicalutamide | 21 |
| Ondansetron Hcl Other prescribers in Pittsburgh, PA | 18 |
| Dexamethasone Other prescribers in Pittsburgh, PA | 16 |
| Prochlorperazine Maleate Other prescribers in Pittsburgh, PA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $183,315 in research payments for these studies, mostly to the institutions running them.
- Expanded Access use of IMDELLTRA in a 63-year-old patient who was diagnosed with DLL3+ small cell bladder cancer
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.